Sector expertise
We specialize in four sectors that are poised for robust and sustainable growth – Health & Wellness, the Food Value Chain, Technology, and Business Services – where our private equity expertise gives us a valuable competitive advantage. Ardian provides our portfolio companies with a strategic partner that offers in-depth market experience and an extensive network within the sector.
-
100+
investments and over 320 build-ups since 1997
Health & Wellness
The sector benefits from long-term, secular growth trends such as: an aging population, rapid technological advancements, an increased focus on well-being, and the spread of chronic diseases. Our team invests across the value chain, from drug development to care delivery, identifying opportunities that improve patient outcomes at every stage.
-
€3.8bn
invested since inception, 20 transactions
-
BuyoutNeopharmed Gentili
Italy
Healthcare & life scienceHealthcare & life scienceNeopharmed Gentili represents the spin-off of the primary care business of Mediolanum Farmaceutici Group and is a leading pharmaceutical company in the Italian market focused on branded prescription drugs in cardiovascular, neurology and allergo-respiratory therapeutic areas, with a portfolio of off-patent and mostly proprietary products. Its flexible and asset-light business model makes Neopharmed Gentili an attractive commercial platform with a proprietary, reliable, and specialized sales force of over 400 pharma representatives.
Deal team
